Bone marrow fibrosis in myelodysplastic syndromes: a prospective evaluation including mutational analysis.
about
Loss of p300 accelerates MDS-associated leukemogenesis.Multidimensional assessment of patient condition and mutational analysis in peripheral blood, as tools to improve outcome prediction in myelodysplastic syndromes: A prospective study of the Spanish MDS group.Bone marrow fibrosis in chronic myelomonocytic leukemia is associated with increased megakaryopoiesis, splenomegaly and with a shorter median time to disease progression.Calreticulin mutations are exceedingly rare in patients with myelodysplastic syndromes with myelofibrosis.The role of p53 in myelodysplastic syndromes and acute myeloid leukemia: molecular aspects and clinical implications.
P2860
Bone marrow fibrosis in myelodysplastic syndromes: a prospective evaluation including mutational analysis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Bone marrow fibrosis in myelod ...... including mutational analysis.
@en
Bone marrow fibrosis in myelod ...... including mutational analysis.
@nl
type
label
Bone marrow fibrosis in myelod ...... including mutational analysis.
@en
Bone marrow fibrosis in myelod ...... including mutational analysis.
@nl
prefLabel
Bone marrow fibrosis in myelod ...... including mutational analysis.
@en
Bone marrow fibrosis in myelod ...... including mutational analysis.
@nl
P2093
P2860
P50
P356
P1433
P1476
Bone marrow fibrosis in myelod ...... including mutational analysis
@en
P2093
Andrés Insunza
Carmen Pedro
Consuelo Del Cañizo
Dimas Suárez-Vilela
Eduardo Salido
Eva Barragán
Fernando Ramos
Francisco Miguel Izquierdo-García
Guillermo F Sanz
Javier Sánchez-Del-Real
P2860
P304
30492-30503
P356
10.18632/ONCOTARGET.9026
P407
P577
2016-05-01T00:00:00Z